Large studies in women with ovarian cancer have shown that there can be a slightly increased risk of ovarian cancer in carriers of ATM PGVs, but there is currently insufficient evidence to recommend risk-reducing salpingo-oophorectomy. The gene discussed is ATM; the disease is ovarian cancer.